Moltó, J., Valle, M., Santos, J. R., Miranda, C., Cedeño, S., Negredo, E., . . . Clotet, B. (2010). Efficacy and safety of ritonavir dose reduction based on the tipranavir inhibitory quotient in HIV-infected patients on salvage antiretroviral therapy with tipranavir/ritonavir.
Citación estilo ChicagoMoltó, José, Marta Valle, José Ramón Santos, Cristina Miranda, Samandhy Cedeño, Eugènia Negredo, Mercedes Yritia, Sebastià Videla, y Bonaventura Clotet. Efficacy and Safety of Ritonavir Dose Reduction Based On the Tipranavir Inhibitory Quotient in HIV-infected Patients On Salvage Antiretroviral Therapy With Tipranavir/ritonavir. 2010.
Cita MLAMoltó, José, et al. Efficacy and Safety of Ritonavir Dose Reduction Based On the Tipranavir Inhibitory Quotient in HIV-infected Patients On Salvage Antiretroviral Therapy With Tipranavir/ritonavir. 2010.